153 related articles for article (PubMed ID: 38452923)
21. Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life.
Agirrezabal I; Brennan VK; Colaone F; Shergill S; Pereira H; Chatellier G; Vilgrain V
Adv Ther; 2022 May; 39(5):2035-2051. PubMed ID: 35279814
[TBL] [Abstract][Full Text] [Related]
22. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
Al-Koussa H; Al-Haddad M; Abi-Habib R; El-Sibai M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795337
[TBL] [Abstract][Full Text] [Related]
23. Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes.
Bobak YP; Vynnytska BO; Kurlishchuk YV; Sibirny AA; Stasyk OV
Cell Biol Int; 2010 Nov; 34(11):1085-9. PubMed ID: 20653567
[TBL] [Abstract][Full Text] [Related]
24. Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma.
Yau T; Cheng PN; Chan P; Chen L; Yuen J; Pang R; Fan ST; Wheatley DN; Poon RT
Invest New Drugs; 2015 Apr; 33(2):496-504. PubMed ID: 25666409
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis and current strategies of therapeutic arginine depletion for cancer.
Fultang L; Vardon A; De Santo C; Mussai F
Int J Cancer; 2016 Aug; 139(3):501-9. PubMed ID: 26913960
[TBL] [Abstract][Full Text] [Related]
26. Arginase release by primary hepatocytes and liver slices results in rapid conversion of arginine to urea in cell culture media.
Peters SJ; Haagsman HP; van Norren K
Toxicol In Vitro; 2008 Jun; 22(4):1094-8. PubMed ID: 18348903
[TBL] [Abstract][Full Text] [Related]
27. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Li J; Wei L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
[TBL] [Abstract][Full Text] [Related]
28. Fluorometric enzymatic assay of l-arginine.
Stasyuk N; Gayda G; Yepremyan H; Stepien A; Gonchar M
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 170():184-90. PubMed ID: 27450117
[TBL] [Abstract][Full Text] [Related]
29. Targeting arginine metabolism pathway to treat arginine-dependent cancers.
Qiu F; Huang J; Sui M
Cancer Lett; 2015 Aug; 364(1):1-7. PubMed ID: 25917076
[TBL] [Abstract][Full Text] [Related]
30. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.
McAlpine JA; Lu HT; Wu KC; Knowles SK; Thomson JA
BMC Cancer; 2014 Aug; 14():621. PubMed ID: 25164070
[TBL] [Abstract][Full Text] [Related]
32. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.
Walton M; Wade R; Claxton L; Sharif-Hurst S; Harden M; Patel J; Rowe I; Hodgson R; Eastwood A
Health Technol Assess; 2020 Sep; 24(48):1-264. PubMed ID: 33001024
[TBL] [Abstract][Full Text] [Related]
33. Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer.
Chung SF; Kim CF; Kwok SY; Tam SY; Chen YW; Chong HC; Leung SL; So PK; Wong KY; Leung YC; Lo WH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545874
[TBL] [Abstract][Full Text] [Related]
34. The significance of arginase-1 expression in the diagnosis of liver cancer: A protocol for a systematic review.
Wang X; Xu Y; Wang R; Dai N; Zhang W; Li F
Medicine (Baltimore); 2020 Feb; 99(9):e19159. PubMed ID: 32118719
[TBL] [Abstract][Full Text] [Related]
35. Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.
Tate DJ; Vonderhaar DJ; Caldas YA; Metoyer T; Patterson JR; Aviles DH; Zea AH
J Hematol Oncol; 2008 Sep; 1():14. PubMed ID: 18817562
[TBL] [Abstract][Full Text] [Related]
36. Review of arginase as a promising biocatalyst: characteristics, preparation, applications and future challenges.
Li M; Qin J; Xiong K; Jiang B; Zhang T
Crit Rev Biotechnol; 2022 Aug; 42(5):651-667. PubMed ID: 34612104
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.
Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA
J Immunol; 2001 Dec; 167(11):6533-44. PubMed ID: 11714822
[TBL] [Abstract][Full Text] [Related]
38. Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine.
Kishikawa T; Otsuka M; Tan PS; Ohno M; Sun X; Yoshikawa T; Shibata C; Takata A; Kojima K; Takehana K; Ohishi M; Ota S; Noyama T; Kondo Y; Sato M; Soga T; Hoshida Y; Koike K
Oncotarget; 2015 Apr; 6(10):8339-52. PubMed ID: 25826076
[TBL] [Abstract][Full Text] [Related]
39. Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.
Abualnil AY; Kumar R; George MA; Lalos A; Shah MM; Deek MP; Jabbour SK
Surg Oncol Clin N Am; 2024 Jan; 33(1):173-195. PubMed ID: 37945142
[TBL] [Abstract][Full Text] [Related]
40. Goals and targets for personalized therapy for HCC.
Couri T; Pillai A
Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
